Navigation Links
The Helmholtz Association and Inserm create 2 joint research laboratories in France
Date:5/27/2011

Inserm and the German Helmholtz Association announce the creation of two Franco-German joint research laboratories to promote interaction between their researchers and to foster the establishment of a new form of cooperation in life sciences and health between the two countries.

The two research laboratories will be set up for an initial period of five years, with an annual funding of 250,000 Euros. The groups, cofinanced by the two institutions, will be located in France, working in close relationship with the two Inserm research centres which offer the most compatible environment and will closely interact with an associated Research Center of the Helmholtz Association. The first will be headed by Julien Marie (Centre de Recherche en Cancrologie, Mixed Research Unit Inserm, Universit Lyon 1-Claude Bernard, CNRS, Centre Lon Brard in Lyons, in cooperation with the German Cancer Research Center, DKFZ, in Heidelberg), and the second by Michael Sieweke (Centre d'immunologie Marseille-Luminy /Mixed Research Unit Inserm, Universit Aix-Marseille 2, CNRS, together with the Max Delbrck Center for Molecular Medicine (MDC) in Berlin).

At Lyons, one scientific project will investigate how cancer cells escape control by the immune system.

Our bodies are confronted by a dilemma when controlling the immune system. To avoid development of autoimmune diseases, certain cells, which would be harmful to the body if they were too active, need to be "concealed". On the other hand, the system must be sufficiently effective to avoid the growth and harmful actions of dangerous cells such as tumour cells. It is probable that these control mechanisms obey common rules and that tumour cells take advantage of faults in the autoimmune system mechanisms to proliferate within an organism. Understanding the mechanisms by which tumours escape control by the immune system is a genuine public health challenge. The research will be based on the preliminary work carried out by the team of Julien Marie, which demonstrated that growth factor TGF β could be a key molecule. The researchers from Inserm together with research groups of the DKFZ want to study the mechanisms of the TGF β activity involved in controlling the immune system. Employing some unique and powerful tools, they will use animal models and human samples obtained by biopsy to examine the cellular and molecular mechanisms by which TGF β makes it possible for tumour cells to escape control of the autoimmune system and recommend targets for therapeutic potential.

Julien Marie is a junior group leader at Inserm. Since 2010, he is the head of the ATIP-Avenir team "TGF-beta and immune evasion" at Lyons. After a three-year postdoctoral position at Seattle, he returned in 2006 to France under a young investigator grant by ANR (Agence Nationale de la Recherche).In 2010, he was awarded by the Bettencourt-Schuller Foundation a Coup d'lan prize for medical research.

At Marseilles, a second scientific project aims to endlessly renew specialized cells without the use of stem cells.

In most cases, once cells have acquired a specialized function (for example: neurons in the brain, muscle cells, macrophages in the immune system, etc.), they cease to divide and normally remain "locked" in this state until death. A team of scientists directed by Michael Sieweke has, however, achieved multiplication of murine macrophages, in vitro, by genetic modification. Moreover, once these modified cells are injected back into the animal, they behave normally; they do not form tumours and are entirely capable to carrying out the tasks expected of adult macrophages, such as ingestion of bacteria and secretion of chemical products to kill them. The collaboration with scientists of the MDC in Berlin will allow new experiments in order to better understand these phenomena which support specialist cell renewal without the involvement of stem cells.

Michael Sieweke is a director of research at CNRS (equivalent to full professor). He is the head of a research team at the CIML (Centre d'immunologie de la mditerrane Marseille Luminy), investigating transcriptional control of the differentiation of macrophages and their function. After studying at Berkeley in the USA and then at Heidelberg in Germany, he returned to France in 1999 under an ATIP program aimed at young researchers. In 2010, he received the AXA prize from the French Academy of Sciences.


'/>"/>

Contact: Priscille Riviere
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. Novel association between Parkinsons disease and prostate cancer
2. Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
3. BIDMC investigator to receive vascular biology award from the American Heart Association
4. The Association for Gerontology in Higher Education honors new officers, awardees
5. The American Association for Cancer Research hosts its 102nd Annual Meeting
6. Dartmouth Medical School faculty named fellows of the American Association for the Advancement of Science
7. Donald M. Lloyd-Jones, M.D., recipient of the American Heart Associations 2010 Chairmans Award
8. National Stroke Association survey reveals more than half of stroke survivors suffer added burden of little known neurologic condition
9. Study examines association between urban living and psychotic disorders
10. Patient safety highlights American Association of Physicists in Medicine
11. Phoenix Dentist Joseph R. Cohen, D.D.S., is Chosen by The American Dental Association's Commission on Dental Accreditation as Site Visitor.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: